Hongwei Doctor طبيب استشاري

المستشفى الثالث التابع لجامعة بكين · Department of Endocrinology · طبيب استشاري

This professional graduated from Peking University Health Science Center (1990) and has served at Peking University Third Hospital's Endocrinology Department since, becoming Chief Physician (2008) and Deputy Director (2006). Research focuses on diabetes and endocrine-reproductive health, with UK visiting research (2001). Published in JAMA and other journals, including co-first authorship on a levothyroxine and miscarriage trial. Received grants from Beijing Natural Science Foundation and nationa

Diabetes, thyroid disorders, and complex endocrine and metabolic diseases, among others.

Hongwei Doctor
معلومات أساسية

About Dr. Hongwei Doctor

المستشفى التابع له
المستشفى الثالث التابع لجامعة بكين
Title
طبيب استشاري
القسم
Department of Endocrinology
عدد سنوات الخبرة
28 سنة (1998 حتى الآن)
Work Experience Graduated from Peking University Health Science Center in 1990 with a Bachelor of Medicine degree. Since graduation, has been working in the Department of Endocrinology at Peking University Third Hospital. Obtained a Master of Medicine degree in 1996 and a Doctor of Medicine degree in 2008. In 2001, conducted one year of visiting research at the School of Life Sciences, Keele University, UK. Appointed as Associate Chief Physician in 2002, and as Associate Professor and Master's Supervisor in 2003. Appointed as Chief Physician in 2008. Has served as Deputy Director of the Department of Endocrinology at Peking University Third Hospital since 2006. Research Work Primary research interests include basic and clinical research on diabetes, and studies on endocrine metabolism and reproductive health. Has successively received funding from projects including the Beijing Natural Science Foundation, the International Medical Exchange Foundation, and the Chinese Medical Association Foundation. As a key project member, participated in the National Key Research and Development Program project: Research on appropriate technologies and efficacy evaluation of early behavioral interventions for risk factors of type 2 diabetes, high diabetes risk, and gestational diabetes mellitus. Awards Received 1 startup fund from the Outstanding Returned Overseas Scholars Program of the hospital and 1 research grant from the "985 Phase II" initiative. Publications 1. Wang H, Gao H (co-first author), Chi H, Zeng L, Xiao W, Wang Y, Li R, Liu P, Wang C, Tian Q, Zhou Z, Yang J, Liu Y, Wei R, Mol BWJ, Hong T, Qiao J. Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer: A Randomized Clinical Trial. JAMA. 2017 Dec 12;318(22):2190-2198. doi: 10.1001/jama.2017.18249. 2. Wen-hua Xiao, Yan-rong Wang, Wen-fang Hou, Chao Xie, Hai-ning Wang, Tian-pei Hong, and Hong-wei Gao (corresponding author). The Effects of Pioglitazone on Biochemical Markers of Bone Turnover in the Patients with Type 2 Diabetes. Int J Endocrinol. 2013;2013:290734, Article ID 290734. 3. Gao H, Xiao W, Wang C, Zhang J, Yang Y, Yang J, Yang W, Hong T. The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study. Int J Clin Pract. 2008, 62:695-700. 4. Gao H, Xie C, Wang H, Lin Y, Hong T. Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes. Acta Pharmacol Sin. 2007, 28: 534–539. 5. Gao H, Wang C, Wang H, Yang X, Li J, Hong T. Lipomatosis of the penis and perineum in a 6-year-old boy. Eur J Pediatr. 2005, 164:115-116. 6. Gao H, Mourtada M, Morgan NG. Effects of the imidazoline binding site ligands, idazoxan and efaroxan, on the viability of insulin-secreting BRIN-BD11 cells. Journal of Pancreas. 2003, 4:117-124. 7. Zhang Shiting, Gao Hongwei (corresponding author), Hong Tianpei. Advances in the diagnosis and treatment of bilateral adrenal masses. Chinese Journal of Minimally Invasive Surgery. 2018, 18(4):349-353. 8. Le Yunyi, Hong Tianpei, Gao Hongwei (corresponding author). Effects of metformin on the hypothalamic-pituitary-gonadal axis and sexual function. 2017, 9(12): 784-786. 9. Wang Chen, Wang Haining, Hong Tianpei, Liu Ye, Tian Qing, Gao Hongwei (corresponding author). Preliminary study of dipeptidyl peptidase-4 inhibitor therapy in patients with polycystic ovary syndrome complicated with abnormal glucose metabolism. Chinese Journal of Diabetes. 2014, 22(10):879-882. 10. Gao Hongwei, Hong Tianpei. The status of glucagon-like peptide-1-based drugs in the treatment of type 2 diabetes. Chinese Journal of Drug Therapy. 2014, 12(1):4-7. 11. Tian Qing, Gao Hongwei (corresponding author), Hong Tianpei. The importance of hemoglobin A1c testing and interpretation of results from a clinical perspective. Chinese Journal of Laboratory Medicine. 2012, 35(6):505-508. 12. Gao Hongwei, Wang Haining, Hong Tianpei. Family history of type 2 diabetes is an independent risk factor for metabolic syndrome in individuals with normal glucose tolerance. Chinese Journal of Diabetes. 2008, 16:83-86. 13. Sun Chunming, Gao Hongwei (corresponding author), Wang Haining, Xie Chao, Hong Tianpei. Study on the effect of nateglinide on reducing postprandial plasma asymmetric dimethylarginine levels in patients with type 2 diabetes. Beijing Medical Journal. 2007, 29:269-272. 14. Gao Hongwei, Hong Tianpei, Yang Wenying, Yang Jinkui, Xiao Wenhua, Wang Chen, Zhang Jinping, Yang Yi. The glucose-lowering efficacy of extended-release metformin and its effects on islet function and insulin resistance. Chinese Journal of Diabetes. 2007, 15:711-713. Books and Translations Chief editor of "The Complete Book of Coping with Diabetes". Participated in the translation and compilation of "Joslin's Diabetes Mellitus", "Harrison's Principles of Internal Medicine", "Oxford Handbook of Clinical Endocrinology", and the eight-year program textbook "Internal Medicine", among others.
وقت العيادة

Hongwei Doctor جدول مواعيد عيادات المدير

الجدول الأسبوعي للعيادات، يشمل العيادات الخارجية / العيادات الخاصة / أيام العمليات. يُنصح بالحجز المسبق قبل 3-7 أيام

Clinic: المستشفى الثالث التابع لجامعة بكين · Department of Endocrinology
On Duty
Off Duty
Period Morning
08:00-12:00
بعد الظهر
14:00-17:30
Evening
18:30-20:30
Mon Off Duty Off Duty Off Duty
Tue Off Duty
13:00 - 17:00
Off Duty
Wed Off Duty
13:00 - 17:00
Off Duty
Thu Off Duty Off Duty Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: يُرجى الاعتماد على إعلان المستشفى في يوم الزيارة الفعلي، ويُنصح بالاتصال بخط Dovecure الساخن على مدار 24 ساعة 400-888-0000 للتأكيد قبل الحجز.
طبيب من نفس المستشفى

فريق الأورام المستشفى الثالث التابع لجامعة بكين

المزيد من أطباء الأورام الرئيسيين المتعاقدين مع مستشفانا

View all

احجز الآن مستشارًا خاصًا

فريق استشاري طبي خبير، بمتوسط خبرة مهنية تتجاوز 5 سنوات، وقد قدم خدمات الرعاية الطبية في الصين لأكثر من 1000 أسرة

احجز الآن مستشارًا خاصًا

فريق استشاري طبي خبير، بمتوسط خبرة مهنية تتجاوز 5 سنوات، وقد قدم خدمات الرعاية الطبية في الصين لأكثر من 1000 أسرة

استشر الآن
استشارة على مدار 7*24 ساعة 400-888-0000
استشارة عبر البريد الإلكتروني cure@dovecure.com
استشارة عبر واتساب WeChat QR Code WeChat QR Code
السلة
عربة التسوق الخاصة بك فارغة
واصل التسوق
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
الإجمالي {{ totalAmount }}
الدفع الآن أدخل عربة التسوق
استشارة